Muzaffer Metintaş

About Muzaffer Metintaş

Muzaffer Metintaş, With an exceptional h-index of 40 and a recent h-index of 22 (since 2020), a distinguished researcher at Eskisehir Osmangazi Üniversitesi, specializes in the field of Pulmonology, Chest Diseases, Pleura, Mesothelioma, Lung Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Image-Assısted Pleural Needle Biopsy or Medical Thoracoscopy: Which Method for Which Patient?–A Randomızed Controlled Trial

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma

Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure

Whole-Genome Comparative Copy Number Alteration Profiling between Malignant Pleural Mesothelioma and Asbestos-Induced Chronic Pleuritis

B. Malignant Pleural Mesothelioma

Clinical, laboratory, and radiologic markers to differentiate benign pleural effusions

Is death from lung cancer associated with socioeconomic development? Turkey sample

Muzaffer Metintaş Information

University

Position

___

Citations(all)

4971

Citations(since 2020)

1408

Cited By

3968

hIndex(all)

40

hIndex(since 2020)

22

i10Index(all)

91

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Muzaffer Metintaş Skills & Research Interests

Pulmonology

Chest Diseases

Pleura

Mesothelioma

Lung Cancer

Top articles of Muzaffer Metintaş

Image-Assısted Pleural Needle Biopsy or Medical Thoracoscopy: Which Method for Which Patient?–A Randomızed Controlled Trial

Chest

2024/3/28

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

Journal of cancer research and clinical oncology

2024/1/27

Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma

Diagnostic Cytopathology

2024/1/20

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure

Journal of Environmental Pathology, Toxicology and Oncology

2024

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Whole-Genome Comparative Copy Number Alteration Profiling between Malignant Pleural Mesothelioma and Asbestos-Induced Chronic Pleuritis

Journal of Environmental Pathology, Toxicology and Oncology

2024

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

B. Malignant Pleural Mesothelioma

2023/10/4

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Clinical, laboratory, and radiologic markers to differentiate benign pleural effusions

2023/9/9

Is death from lung cancer associated with socioeconomic development? Turkey sample

2023/9/9

Post-COVID-19 syndrome in a cohort of hospitalized COVID-19 patients.

European Review for Medical & Pharmacological Sciences

2023/9/1

Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma

Journal of Cancer Research and Clinical Oncology

2023/8

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Benign and Malignant Tumor Segmentation on Thorax Computed Tomography Images

2023/7/5

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers

Cancer Biomarkers

2023/1/1

Response Prediction in Lung SBRT with Artificial Intelligence

TURK ONKOLOJI DERGISI

2023

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Gene variations of chemokine and chemokine receptor CXCL12/CXCR4 in lung cancer

Journal of Environmental Pathology, Toxicology and Oncology

2023

Guntulu Ak
Guntulu Ak

H-Index: 15

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Hulyam Kurt
Hulyam Kurt

H-Index: 10

Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma

Archives of medical science: AMS

2023

Evaluation of the contribution of fine-needle non-aspiration cytology to diagnosis in cases with pulmonary malignant lesions

Turkish Journal of Medical Sciences

2022

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Evaluation of exudative pleural effusions: a multicenter, prospective, observational study

Lung

2022/12

Serum expression levels of certain miRNAs in predicting diagnosis, prognosis, and response to chemotherapy in malignant pleural mesothelioma

Balkan Medical Journal

2022/7

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

What has changed in malignant mesothelioma between 1990 and 2019? A time-series analyses in Turkey

International Journal of Clinical Oncology

2022/7

See List of Professors in Muzaffer Metintaş University(Eskisehir Osmangazi Üniversitesi)